Stay updated on Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.

Latest updates to the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.2 has been added. Ovarian cancer, related topics (MedlinePlus Genetics), and Revision: v3.5.0 have been removed.SummaryDifference0.2%

- Check12 days agoChange DetectedAdded related topics: Ovarian cancer and MedlinePlus Genetics to the study page.SummaryDifference0.2%

- Check19 days agoChange DetectedThe related topic entries for 'Ovarian cancer' and 'MedlinePlus Genetics' have been removed.SummaryDifference0.2%

- Check27 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded a related topics section for ovarian cancer with a link to MedlinePlus Genetics.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision: v3.4.3 was added; the Ovarian cancer-related topics were removed from the related topics. The core study details remain unchanged.SummaryDifference0.2%

Stay in the know with updates to Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.